Abiopharma

Clinical trial NCT07623174: start date: 2026-07-01 → 2026-07-31.

Clinical trial NCT05451771 updates: 1. completion date: 2026-09-01 → 2027-09-01 2. primary completion date: 2026-09-01 → 2027-09-01

Clinical trial NCT06830798 updates: 1. completion date: 2028-11-06 → 2028-08-30 2. primary completion date: 2028-02-04 → 2027-11-30

Appointment of director - Rami Hazzan, starting from 18.6.26

FORM 6-K- Perion Launches Ask Perion, an Agentic Self-Serve Mobile App Designed to Accelerate Omnichannel Execution and Increase Efficiency

METRO AG Achieves Major Milestone in Partnership with Wipro Towards AI-Led Transformation

Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm

Primech Holdings Secures Approximately US$36.1 Million in New Social Services and Public Sector Integrated Facility Services Contracts

PARKE BANCORP, INC. ANNOUNCES CASH DIVIDEND

Formation of Treasury Shares in the Issued Share Capital of Phoenix Financial Ltd